Un nuevo medicamento le ofrece más tiempo a las pacientes con un cáncer de endometrio avanzado
MARTES, 28 de marzo de 2023 (HealthDay News) — Unos investigadores han descubierto que dos medicamentos quizá sean mejor que uno para las mujeres que tienen un cáncer de endometrio avanzado.Combinar la quimioterapia con la inmunoterapia o un anticuer…
Learn MoreLa extirpación de los ovarios en la juventud podría aumentar el riesgo de Parkinson
LUNES, 27 de marzo de 2023 (HealthDay News) — Las mujeres que se someten a la extirpación de ambos ovarios antes de los 43 años tienen un riesgo más alto de desarrollar enfermedad de Parkinson, o parkinsonismo, según un estudio reciente. Esto podría …
Learn MoreNew Drug Combo Buys More Time for Advanced Endometrial Cancer Patients
TUESDAY, March 28, 2023 (HealthDay News) — Researchers have discovered that two drugs might be better than one for women who have advanced endometrial cancer.Combining chemotherapy and immunotherapy or a monoclonal antibody at the same time helped th…
Learn MoreOvary Removal When Young Could Raise Parkinson’s Risk
MONDAY, March 27, 2023 (HealthDay News) — Women who have both of their ovaries removed before age 43 have an increased risk of developing Parkinson’s disease or parkinsonism, according to a recent study.This may owe to the sudden loss of estrogen and…
Learn MoreMaternal Opioids After Delivery Not Linked to Adverse Infant Outcomes
FRIDAY, March 24, 2023 (HealthDay News) — Maternal opioid prescription after delivery seems not to be associated with adverse infant outcomes, including admission to the hospital or death, according to a study published March 15 in The BMJ.Jonathan S…
Learn MoreAsocian las pastillas anticonceptivas de cualquier fórmula con un leve aumento en el riesgo de cáncer de mama
MIÉRCOLES, 22 de marzo de 2023 (HealthDay News) — Tomar pastillas anticonceptivas de progestágeno solo conlleva un ligero aumento en el riesgo de cáncer de mama, alrededor del mismo nivel de riesgo asociado con tomar pastillas que contengan tanto pro…
Learn MoreIUD Placement at Two to Four Weeks Postpartum Noninferior
THURSDAY, March 23, 2023 (HealthDay News) — Intrauterine device (IUD) placement at two to four weeks postpartum is noninferior to placement at six to eight weeks postpartum for complete expulsion, according to a study published in the March 21 issue …
Learn MoreSlight Increase in Breast Cancer Risk Seen With Progestogen-Only Contraceptives
WEDNESDAY, March 22, 2023 (HealthDay News) — Progestogen-only contraceptive use is associated with a slight increase in breast cancer risk, according to a study published online March 21 in PLOS Medicine.Danielle Fitzpatrick, M.B.B.S., M.P.H., from t…
Learn MoreBirth Control Pills Tied to Slight Rise in Breast Cancer Risk, Regardless of Formulation
WEDNESDAY, March 22, 2023 (HealthDay News) — Taking progestogen-only birth control pills comes with a slightly increased risk of breast cancer — about the same degree of risk associated with taking pills that contain both progestogen and estrogen, n…
Learn MorePara las mujeres con Medicaid, resulta difícil acceder a los DIU y los implantes anticonceptivos
LUNES, 20 de marzo de 2023 (HealthDay News) — Las personas cubiertas por el seguro de Medicaid no tienen un acceso fácil a algunos de los métodos anticonceptivos más efectivos y de larga acción, señala una nueva investigación.Los investigadores encon…
Learn More